Barsanti Cristina, Trivella Maria Giovanna, D'Aurizio Romina, El Baroudi Mariama, Baumgart Mario, Groth Marco, Caruso Raffaele, Verde Alessandro, Botta Luca, Cozzi Lorena, Pitto Letizia
Institute of Clinical Physiology, National Research Council, CNR, Via Moruzzi 1, 56124 Pisa, Italy ; Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, 56127 Pisa, Italy.
Institute of Clinical Physiology, National Research Council, CNR, Via Moruzzi 1, 56124 Pisa, Italy.
Biomed Res Int. 2015;2015:592512. doi: 10.1155/2015/592512. Epub 2015 Feb 1.
Mechanical unloading by left ventricular assist devices (LVADs) in advanced heart failure (HF), in addition to improving symptoms and end-organ perfusion, is supposed to stimulate cellular and molecular responses which can reverse maladaptive cardiac remodeling. As microRNAs (miRNAs) are key regulators in remodeling processes, a comparative miRNA profiling in transplanted hearts of HF patients with/without LVAD assistance could aid to comprehend underlying molecular mechanisms. Next generation sequencing (NGS) was used to analyze miRNA differential expression in left ventricles of HF patients who underwent heart transplantation directly (n = 9) or following a period of LVAD support (n = 8). After data validation by quantitative real-time PCR, association with functional clinical parameters was investigated. Bioinformatics' tools were then used for prediction of putative targets of modulated miRNAs and relative pathway enrichment. The analysis revealed 13 upregulated and 10 downregulated miRNAs in failing hearts subjected to LVAD assistance. In particular, the expression level of some of them (miR-338-3p, miR-142-5p and -3p, miR-216a-5p, miR-223-3p, miR-27a-5p, and miR-378g) showed correlation with off-pump cardiac index values. Predicted targets of these miRNAs were involved in focal adhesion/integrin pathway and in actin cytoskeleton regulation. The identified miRNAs might contribute to molecular regulation of reverse remodeling and heart recovery mechanisms.
在晚期心力衰竭(HF)中,通过左心室辅助装置(LVAD)进行机械卸载,除了改善症状和终末器官灌注外,还被认为可以刺激细胞和分子反应,从而逆转适应性不良的心脏重塑。由于微小RNA(miRNA)是重塑过程中的关键调节因子,对有/无LVAD辅助的HF患者移植心脏进行比较性miRNA谱分析,有助于理解潜在的分子机制。采用下一代测序(NGS)分析直接接受心脏移植(n = 9)或经过一段时间LVAD支持后接受心脏移植(n = 8)的HF患者左心室中的miRNA差异表达。通过定量实时PCR进行数据验证后,研究其与功能性临床参数的相关性。然后使用生物信息学工具预测调控miRNA的推定靶标和相关途径富集情况。分析显示,在接受LVAD辅助的衰竭心脏中,有13种miRNA上调,10种miRNA下调。特别是其中一些miRNA(miR-338-3p、miR-142-5p和-3p、miR-216a-5p、miR-223-3p、miR-27a-5p和miR-378g)的表达水平与非体外循环心脏指数值相关。这些miRNA的预测靶标参与粘着斑/整合素途径和肌动蛋白细胞骨架调节。所鉴定的miRNA可能有助于逆向重塑和心脏恢复机制的分子调节。